The Middle East pharmaceutical market continues to expand, expected to reach around USD 78 billion by 2033 as healthcare investment and local manufacturing accelerate across the region. The sectors are:
Three sectors seeing strong growth include:
- Excipients: Supporting stability, solubility, and performance in modern formulations. The Middle East excipient market was valued at USD 278.9 million in 2024 and is projected to reach USD 354.7 million by 2033.
- Packaging & Drug Delivery: Technologies improving drug safety, traceability, and patient adherence. The Middle East pharmaceutical packaging market is valued at around USD 3.3 billion and continues to grow as demand for secure and advanced delivery formats increases.
- Generics & Finished Dosage Forms: Essential for medicine access across the region. Small molecule medicines account for more than 54% of the Middle East pharmaceutical market, supported by localisation programmes and regional manufacturing growth.
CPHI Middle East (11 – 13 May 2026) brings together the companies, regulators, and technology providers active across these sectors.
See also https://blog.bimpress.de/mena-arab-region-delegation-trips-medtech-health/ for more.
